[{"AccountsPayableCurrent_0_Q1_USD":466000000.0,"AmortizationOfFinancingCosts_1_Q1_USD":1000000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":45000000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":9000000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q1_USD":605000000.0,"OtherLiabilitiesCurrent_0_Q1_USD":180000000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q1_USD":-22000000.0,"ProceedsFromLinesOfCredit_1_Q1_USD":190000000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":205000000.0,"OciBeforeReclassificationsNetOfTaxAttributableToParent_1_Q1_USD":-30000000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q1_USD":-63000000.0,"PaymentsOfDividendsCommonStock_1_Q1_USD":0.0,"GainLossOnSaleOfPropertyPlantEquipment_1_Q1_USD":1000000.0,"EarningsPerShareDiluted_1_Q1_USD":-0.3,"RepaymentsOfLongTermDebt_1_Q1_USD":17000000.0,"ProceedsFromIssuanceOfLongTermDebt_1_Q1_USD":0.0,"LongTermDebtCurrent_0_Q1_USD":61000000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":40000000.0,"DeferredIncomeTaxExpenseBenefit_1_Q1_USD":-5000000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q1_USD":-35000000.0,"TaxesPayableCurrent_0_Q1_USD":28000000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q1_USD":-30000000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":-30000000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1_Q1_USD":1000000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-64000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":112000000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":132000000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q1_shares":0.0,"InterestIncomeExpenseNonoperatingNet_1_Q1_USD":-14000000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":9000000.0,"TemporaryEquityForeignCurrencyTranslationAdjustments_1_Q1_USD":-1000000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q1_USD":46000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":1065000000.0,"RedeemableNoncontrollingInterestEquityCarryingAmount_0_Q1_USD":9000000.0,"ProceedsFromContributionsFromParent_1_Q1_USD":0.0,"PaymentsToMinorityShareholders_1_Q1_USD":0.0,"PaymentsToAcquireBusinessesAndInterestInAffiliates_1_Q1_USD":0.0,"PaymentsForRestructuring_1_Q1_USD":6000000.0,"OtherReceivablesGrossCurrent_0_Q1_USD":70000000.0,"OtherOperatingActivitiesCashFlowStatement_1_Q1_USD":1000000.0,"OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax_1_Q1_USD":-8000000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest_1_Q1_USD":1000000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q1_USD":0.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":123000000.0,"NumberOfInterestRateDerivativesHeld_0_Q1_swap":5.0,"NetIncomeLossAttributableToRedeemableNoncontrollingInterest_1_Q1_USD":0.0,"LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_0_Q1_USD":1381000000.0,"LongTermDebtAndCapitalLeaseObligationsCurrent_0_Q1_USD":61000000.0,"LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_0_Q1_USD":20000000.0,"InvestmentIncomeNonoperating_1_Q1_USD":0.0,"InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_0_Q1_USD":5000000.0,"IncreaseDecreaseInOtherOperatingCapitalNet_1_Q1_USD":-5000000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1_Q1_USD":-1000000.0,"ContractWithCustomerLiabilityCurrent_0_Q1_USD":37000000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":75000000.0,"BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed_1_Q1_USD":7000000.0,"OperatingLeasePaymentsUse_1_Q1_USD":6000000.0,"TemporaryEquityNetIncome_1_Q1_USD":0.0,"PaymentsOfMergerRelatedCostsFinancingActivities_1_Q1_USD":9000000.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q1_USD":0.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":94000000.0,"ProfitLoss_1_Q1_USD":-33000000.0,"ProceedsFromSaleOfPropertyPlantAndEquipment_1_Q1_USD":4000000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":40000000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":11000000.0,"NetIncomeLoss_1_Q1_USD":-33000000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-76000000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-7000000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":159000000.0,"LiabilitiesCurrent_0_Q1_USD":800000000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":3487000000.0,"Liabilities_0_Q1_USD":2276000000.0,"InventoryNet_0_Q1_USD":572000000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":112000000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":-2000000.0,"GrossProfit_1_Q1_USD":202000000.0,"CommonStockValue_0_Q1_USD":1000000.0,"CommonStockSharesOutstanding_0_Q1_shares":111854439.0,"CommonStockSharesIssued_0_Q1_shares":111854439.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":205000000.0,"AssetsCurrent_0_Q1_USD":1460000000.0,"Assets_0_Q1_USD":3487000000.0,"AdditionalPaidInCapital_0_Q1_USD":2390000000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-116000000.0,"AccountsReceivableNetCurrent_0_Q1_USD":525000000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-1073000000.0,"StockholdersEquity_0_Q1_USD":1202000000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.01,"LongTermDebtNoncurrent_0_Q1_USD":1298000000.0,"InvestmentsAndOtherNoncurrentAssets_0_Q1_USD":51000000.0,"Goodwill_0_Q1_USD":1154000000.0,"EarningsPerShareBasic_1_Q1_USD":-0.3,"CostOfGoodsAndServicesSold_1_Q1_USD":863000000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":-1000000.0,"FiniteLivedIntangibleAssetsNet_0_Q1_USD":605000000.0,"FiniteLivedIntangibleAssetsGross_0_Q1_USD":990000000.0,"DebtInstrumentUnamortizedDiscount_0_Q1_USD":22000000.0,"LongTermDebtAndCapitalLeaseObligations_0_Q1_USD":1320000000.0,"IncreaseDecreaseInInventories_1_Q1_USD":-44000000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1_Q1_USD":-31000000.0,"PaymentsOfDebtIssuanceCosts_1_Q1_USD":5000000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q1_pure":0.057,"AmortizationOfIntangibleAssets_1_Q1_USD":34000000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q1_USD":8000000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":89000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":112000000.0,"ShareBasedCompensation_1_Q1_USD":9000000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":222000000.0,"OperatingIncomeLoss_1_Q1_USD":-20000000.0,"InterestPaidNet_1_Q1_USD":12000000.0,"InterestExpense_1_Q1_USD":14000000.0,"IncomeTaxesPaidNet_1_Q1_USD":4000000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q1_USD":385000000.0,"CommonStockSharesAuthorized_0_Q1_shares":675000000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q1_USD":46000000.0,"UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount_0_Q1_USD":47000000.0,"Ticker":"CVET","CIK":"1752836","name":"COVETRUS, INC.","OfficialName":"Covetrus Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2248425517.0","Country":"United States","Sector":"Health Care","Industry":"Other Pharmaceuticals","Market":"NASDAQ","SP500":"nan","filed":"20200514"}]